What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Bacteria
Howard S. Gold mainly focuses on Microbiology, Staphylococcus aureus, Antibacterial agent, Staphylococcal infections and Methicillin-resistant Staphylococcus aureus.
Howard S. Gold combines subjects such as Vancomycin and Linezolid with his study of Microbiology.
His Vancomycin research focuses on subjects like Glycopeptide, which are linked to Hemolysin.
The Staphylococcus aureus study combines topics in areas such as Odds ratio, Hospitalized patients, Case-control study, Levofloxacin and Risk factor.
As a part of the same scientific study, Howard S. Gold usually deals with the Antibacterial agent, concentrating on Antimicrobial and frequently concerns with Peritonitis.
His work deals with themes such as Agar dilution, Daptomycin, Osteomyelitis, Vertebral osteomyelitis and Bacteremia, which intersect with Methicillin-resistant Staphylococcus aureus.
His most cited work include:
- Antimicrobial-drug resistance (903 citations)
- Linezolid resistance in a clinical isolate of Staphylococcus aureus (857 citations)
- Linezolid resistance in a clinical isolate of Staphylococcus aureus (857 citations)
What are the main themes of his work throughout his whole career to date?
Howard S. Gold focuses on Microbiology, Antibacterial agent, Internal medicine, Antibiotics and Staphylococcus aureus.
Howard S. Gold has included themes like Vancomycin, Linezolid and Methicillin-resistant Staphylococcus aureus in his Microbiology study.
His Antibacterial agent study combines topics from a wide range of disciplines, such as Enterococcus faecium, Antimicrobial and Enterococcus faecalis, Enterobacteriaceae, Escherichia coli.
His studies in Internal medicine integrate themes in fields like Surgery, Cefazolin and Cephalosporin.
His study looks at the relationship between Antibiotics and fields such as Intensive care medicine, as well as how they intersect with chemical problems.
His Staphylococcus aureus research integrates issues from Bacteremia and Virology.
He most often published in these fields:
- Microbiology (69.00%)
- Antibacterial agent (44.00%)
- Internal medicine (28.00%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (28.00%)
- Antimicrobial stewardship (16.00%)
- Intensive care medicine (19.00%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Antimicrobial stewardship, Intensive care medicine, Clostridioides and Bacteremia.
The study incorporates disciplines such as Cefazolin and Diabetic foot infections in addition to Internal medicine.
His Intensive care medicine research incorporates themes from Liver disease and Sepsis.
The concepts of his Perioperative study are interwoven with issues in Antimicrobial and Retrospective cohort study.
His studies deal with areas such as Hazard ratio and Confidence interval as well as Antimicrobial.
His Vancomycin study incorporates themes from Ceftazidime, Cefepime, Antibiotics and Meropenem.
Between 2017 and 2021, his most popular works were:
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). (312 citations)
- Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program. (9 citations)
- Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections. (6 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Bacteria
His scientific interests lie mostly in Internal medicine, Emergency medicine, Acute kidney injury, Interquartile range and Nafcillin.
His Emergency medicine research includes themes of Discontinuation and Infection control.
His biological study spans a wide range of topics, including Clostridium difficile, Incidence, Antimicrobial, Vancomycin and Hazard ratio.
His research in Interquartile range intersects with topics in QT interval, Torsades de pointes, Cohort study and Pneumonia.
His Cohort study research incorporates elements of Concomitant and Azithromycin.
His Nafcillin research is multidisciplinary, relying on both Bacteremia, APACHE II, Cefazolin and Empiric therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
